SHAREHOLDERS' EQUITY:

6 Months Ended

Dec. 31, 2012

SHAREHOLDERS' EQUITY:

SHAREHOLDERS' EQUITY:

3. SHAREHOLDERS’ EQUITY:

Net (Loss) Income Per Share:

The Company’s basic earnings per share is calculated as net (loss) income divided by weighted average common shares outstanding, excluding unvested outstanding RSAs and RSUs. The Company’s dilutive earnings per share is calculated as net (loss) income divided by weighted average common shares and common share equivalents outstanding, which includes shares issuable under the Company’s stock option plan and long-term incentive plan. Stock-based awards with exercise prices greater than the average market value of the Company’s common stock are excluded from the computation of diluted earnings per share. The Company’s dilutive earnings per share will also reflect the assumed conversion under the Company’s convertible debt if the impact is dilutive, along with the exclusion of interest expense, net of taxes. The impact of the convertible debt is excluded from the computation of diluted earnings per share when interest expense per common share obtainable upon conversion is greater than basic earnings per share.

The following table sets forth a reconciliation of the net (loss) income from continuing operations available to common shareholders and the net (loss) income from continuing operations for diluted earnings per share under the if-converted method:

	For the Periods Ended December 31,
	Three Months					Six Months
	2012			2011		2012		2011
	(Dollars in thousands)
Net (loss) income from continuing operations available to common shareholders	$	(16,119	)	$	11,900	$	18,528	$	17,523
Effect of dilutive securities:
Interest on convertible debt, net of taxes	—			2,078		—		—
Net (loss) income from continuing operations for diluted earnings per share	$	(16,119	)	$	13,978	$	18,528	$	17,523

The following table sets forth a reconciliation of shares used in the computation of basic and diluted earnings per share:

	For the Periods Ended December 31,
	Three Months		Six Months
	2012	2011	2012	2011
	(Shares in thousands)
Weighted average shares for basic earnings per share	56,794	56,857	57,043	56,853
Effect of dilutive securities:
Dilutive effect of stock-based compensation (1)	—	357	82	306
Dilutive effect of convertible debt	—	11,203	—	—
Weighted average shares for diluted earnings per share	56,794	68,417	57,125	57,159

(1) For the three months ended December 31, 2012, 98,637 common stock equivalents of potentially dilutive common stock were not included in the diluted earnings per share calculation because to do so would have been anti-dilutive.

The following table sets forth the awards which are excluded from the various earnings per share calculations:

	For the Periods Ended December 31,
	Three Months		Six Months
	2012	2011	2012	2011
	(Shares in thousands)		(Shares in thousands)
Basic earnings per share:
RSAs (1)	482	791	482	791
RSUs (1)	189	215	189	215
	671	1,006	671	1,006
Diluted earnings per share:
Stock options (2)	579	810	600	810
SARs (2)	1,001	999	895	999
RSAs (2)	—	6	—	203
RSUs (2)	180	—	93	—
Shares issuable upon conversion of debt (3)	11,255	—	11,247	11,195
	13,015	1,815	12,835	13,207

(1) Shares were not vested

(2) Shares were anti-dilutive

(3) Share equivalents were anti-dilutive for the three and six months ended December 31, 2012 and for the six months ended December 31, 2011.

Additional Paid-In Capital:

The $12.6 million decrease in additional paid-in capital during the six months ended December 31, 2012 was due to repurchases of common stock partially offset by stock-based compensation.

In May 2000, the Company’s Board of Directors approved a stock repurchase program. To date, a total of $300.0 million has been authorized to be expended for the repurchase of the Company’s stock. All repurchased shares become authorized but unissued shares of the Company. This repurchase program has no stated expiration date.  During the three months ended December 31, 2012, the Company repurchased 909,175 shares for $14.9 million. At December 31, 2012, $58.7 million remains outstanding on the approved stock repurchase program.

Accumulated Other Comprehensive Income:

The Company completed the sale of its investment in Provalliance during the quarter ended September 30, 2012 and subsequently liquidated all foreign entities with Euro denominated operations.  Amounts previously classified within accumulated other comprehensive income that were recognized in earnings were foreign currency translation rate gain adjustments of $43.4 million, a cumulative tax-effected net loss of $7.9 million associated with a cross-currency swap that was settled in fiscal year 2007 that hedged the Company’s European operations, and a $1.7 million net loss associated with cash repatriation, which nets to $33.8 million for the six months ended December 31, 2012.